5:10 PM
 | 
Nov 09, 2018
 |  BC Extra  |  Preclinical News

June highlights shorter CAR T culture times at SITC

In a presentation at the Society for Immunotherapy of Cancer (SITC) meeting Friday, CAR T cell pioneer Carl June highlighted preclinical data from University of Pennsylvania suggesting CAR T cell therapies could require as little as three days of culture time, and shorter cultures could actually improve the cells' antitumor effects in vivo.

Shorter culture times for clinical CAR T cell products would cut waiting periods for patients and reduce the cost and labor required to produce the therapies, which could increase manufacturing efficiency and patient access.

The data, first published in...

Read the full 438 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >